China's Robot Giants AGIBOT, Unitree Eye IPOs

The race to capitalize on China's rapidly advancing embodied artificial intelligence sector is heating up, with two prominent humanoid robot developers, AGIBOT and Unitree Robotics, charting distinct paths toward public market debuts. This dual push signals a pivotal moment for the nation's ambitions in advanced robotics and AI, potentially unlocking significant capital for further innovation and global expansion.

AGIBOT, a Shanghai-based entity now operating as AGIBOT Innovation (Shanghai) Technology Co. Ltd., has officially commenced its initial public offering process in Hong Kong. This move positions the company to be the vanguard of an anticipated wave of 30 to 50 Chinese embodied AI startups seeking public listings. The company has already garnered substantial support from industry heavyweights, including strategic investments from tech titans Tencent Holdings and JD.com, alongside automotive giant SAIC Motor, during its 2025 funding rounds. Following a significant funding round led by Tencent Holdings in March 2025, AGIBOT achieved a valuation exceeding 20 billion yuan (approximately $3 billion). By mid-2026, the company reported a notable achievement in mass production, having manufactured 15,000 embodied AI robots, and has also launched a robot rental service named Qingtian Rent.

Meanwhile, Unitree Robotics, a leading force in China's humanoid robot manufacturing and notably one of the few physical AI firms demonstrating profitability, is targeting a listing on the Shanghai STAR Market. Having secured domestic A-share listing approval in July 2026, Unitree Robotics is set to pioneer the entry of humanoid robot companies into the mainland Chinese stock exchange. The company's subscription period is slated to open on August 10, 2026, with an anticipated listing around August 19, 2026. Projections suggest a post-IPO valuation approaching 42 billion yuan, with external estimates from CCB International in Hong Kong placing its corporate value significantly higher at 109 billion yuan.

Unitree Robotics' fundraising strategy involves issuing 40.446 million new shares, representing 10% of its post-IPO equity. The company aims to secure approximately 4.2 billion yuan, earmarked for critical investments in AI model research tailored for robotics, the development of new product lines, and the scaling up of its manufacturing capabilities. The company's financial health is robust, evidenced by a substantial surge in prior year revenue, exceeding fourfold to 1.71 billion yuan, and a net profit that more than doubled to 287.6 million yuan.

Both companies are actively pursuing international growth. AGIBOT has extended its reach into eight European nations, while Unitree Robotics has strategically diversified its global footprint. In 2025, U.S. sales constituted 13.3% of Unitree Robotics' revenue, a decrease from previous years, reflecting a deliberate pivot towards expanding its presence in Europe and Southeast Asia. This global expansion is occurring within a dynamic geopolitical context, underscoring China's escalating competitiveness in the embodied AI robotics arena. Industry observers estimate that approximately 19 Chinese smart device and humanoid robot firms are currently preparing for public offerings, with many in advanced stages of regulatory review.

The concurrent IPO announcements from AGIBOT and Unitree Robotics represent a significant validation for China's embodied AI sector. These public market entries are expected to attract considerable investor interest, highlighting the growing commercial viability and investment potential of humanoid robotics on a global scale.